About this market
Development of biodegradable annuloplasty rings to drive growth in the market. Biodegradable annuloplasty rings have several advantages over rigid and flexible annuloplasty rings. Biodegradable annuloplasty rings have less gradient, better posterior leaflet mobility, and faster recovery of the shortening fraction after recovery. The analysts have predicted that the annuloplasty rings market will register a CAGR of more than 4% by 2023.
Market Overview
Increasing preference of mitral valve repair over mitral valve replacement
Mitral valve repair is the most preferred option for nearly all patients with a regurgitant mitral valve and for a significant proportion of patients with stenotic mitral valve.
Lack of awareness and shortage of skilled cardiologists
Despite the increasing prevalence of heart valve diseases, the public awareness of the disease is significantly low in several developing as well as developed countries.
For the detailed list of factors that will drive and challenge the growth of the annuloplasty rings market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including LivaNova and Medtronic the competitive environment is quite intense. Factors such as the rising preference of mitral valve repair over mitral valve replacement and the development of biodegradable annuloplasty rings, will provide considerable growth opportunities to annuloplasty rings manufactures. Abbott, Edwards Lifesciences, LivaNova, and Medtronic are some of the major companies covered in this report.